DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
RoboCT, a technology-driven enterprise, takes technology innovation as its core driving force and is committed to exoskeleton robot technology, robot core components and intelligent control technology. They focus on the fields of rehabilitation and elderly care through the combination of human-computer interaction technology, artificial intelligence technology, data analysis and cloud computing, providing intelligent products and solutions for medical and healthcare institutions and individual users.
Website
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.